Search Results - "metastasis"

VEGF inhibitors for anti-angiogenic therapy

Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
Get full text
Series

VEGF inhibitors for anti-angiogenic therapy

Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
Get full text
Series

VEGF inhibitors for anti-angiogenic therapy

Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
Get full text
Series

VEGF inhibitors for anti-angiogenic therapy

Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
Get full text
Series

VEGF inhibitors for anti-angiogenic therapy

Table of Contents: “…Contents: Antagonist monoclonal antibodies to VEGFR-3 -- Mode of action of antagonist monoclonal antibodies -- Functional properties of antagonist antibodies to VEGFR-3 -- In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis -- Inhibition of pathological vessel growth in the cornea -- Anti-angiogenic effect of antibodies to VEGFR-3 in tumors -- Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3 -- Role of VEGFR-3 in normal and pathological immune response.…”
Get full text
Series

Cancer as a metabolic disease on the origin, management, and prevention of cancer / by Seyfried, Thomas N., 1946-

Table of Contents: “…-- Genes, respiration, viruses, and cancer -- Respiratory injury, the retrograde response, and the origin of cancer -- Mitochondria: the ultimate tumor suppressor -- Linking abnormalities in growth control, telomerase activity, apoptosis, and angiogenesis to mitochondrial dysfunction -- Metastasis -- Mitochondrial respiratory dysfunction and the extrachromosomal origin of cancer -- Nothing in cancer biology makes sense except in the light of evolution -- Cancer treatment strategies -- Metabolic management of cancer -- Implementation of metabolic therapies for cancer management -- Cancer prevention -- Case studies and personal experiences in using the ketogenic diet for cancer management.…”
An electronic book accessible through the World Wide Web; click to view

Cancer and stem cells

Table of Contents: “…Nikitin -- Cancer stem cells and metastasis / Benjamin Tiede and Yibin Kang -- Exercise, stem cells, and cancer / Emre Tunca, Karsten Krüger, Frank C. …”
An electronic book accessible through the World Wide Web; click to view

Clinical applications of molecular imaging imaging to guide cancer therapy /

Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series

Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /

Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series

Clinical applications of molecular imaging imaging to guide cancer therapy /

Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series

Clinical applications of molecular imaging imaging to guide cancer therapy /

Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series

Liver cancer causes, diagnosis and treatment /

Table of Contents: “….] -- Treatment of liver metastasis of colorectal cancer / Hiroyuki Uetake.…”
An electronic book accessible through the World Wide Web; click to view

Molecular Cancer

Open Access

Molecular Cancer

Open Access

Tumor-associated macrophages

Table of Contents: “…Contents: The correlation between Tumor Associated Macrophage (TAM) infiltration and tumor progression in cancer patients -- Evidence for a protumoral function of TAMs in mouse tumor models -- Hallmark features of TAMs enable tumor progression -- Promotion of inflammation -- Chronic inflammatory diseases and cancer risk -- Promotion of matrix remodeling -- Promotion of tumor cell invasion -- Promotion of metastasis -- Promotion of angiogenesis -- TAM heterogeneity in tumors -- Identification and characterization of TAM subsets in mouse tumor models -- TIE2-expressing macrophages and inflammatory TAMs -- Origins of TAM subsets: Distinct hypothesis -- Tumor responses to anticancer therapies: Role of TAMs -- Reprogramming TAMs from a pro- to an anti-tumoral function -- Deciphering TAM heterogeneity in human cancer -- Complexity of leukocyte infiltrates in human cancer.…”
Get full text
Series

Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /

Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series

Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /

Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series

Colorectal cancer risk, diagnosis and treatments /

Table of Contents: “….] -- Serum CSE1L and CEA for prognosis of metastatic colorectal cancer / Ming-Chung Jiang -- Radiofrequency ablation as a novel therapy for pulmonary metastasis from colorectal cancer / Takao Hiraki ... …”
An electronic book accessible through the World Wide Web; click to view

Tumor-associated macrophages

Table of Contents: “…Contents: The correlation between Tumor Associated Macrophage (TAM) infiltration and tumor progression in cancer patients -- Evidence for a protumoral function of TAMs in mouse tumor models -- Hallmark features of TAMs enable tumor progression -- Promotion of inflammation -- Chronic inflammatory diseases and cancer risk -- Promotion of matrix remodeling -- Promotion of tumor cell invasion -- Promotion of metastasis -- Promotion of angiogenesis -- TAM heterogeneity in tumors -- Identification and characterization of TAM subsets in mouse tumor models -- TIE2-expressing macrophages and inflammatory TAMs -- Origins of TAM subsets: Distinct hypothesis -- Tumor responses to anticancer therapies: Role of TAMs -- Reprogramming TAMs from a pro- to an anti-tumoral function -- Deciphering TAM heterogeneity in human cancer -- Complexity of leukocyte infiltrates in human cancer.…”
Get full text
Series

Tumor-associated macrophages

Table of Contents: “…Contents: The correlation between Tumor Associated Macrophage (TAM) infiltration and tumor progression in cancer patients -- Evidence for a protumoral function of TAMs in mouse tumor models -- Hallmark features of TAMs enable tumor progression -- Promotion of inflammation -- Chronic inflammatory diseases and cancer risk -- Promotion of matrix remodeling -- Promotion of tumor cell invasion -- Promotion of metastasis -- Promotion of angiogenesis -- TAM heterogeneity in tumors -- Identification and characterization of TAM subsets in mouse tumor models -- TIE2-expressing macrophages and inflammatory TAMs -- Origins of TAM subsets: Distinct hypothesis -- Tumor responses to anticancer therapies: Role of TAMs -- Reprogramming TAMs from a pro- to an anti-tumoral function -- Deciphering TAM heterogeneity in human cancer -- Complexity of leukocyte infiltrates in human cancer.…”
Get full text
Series